Morgan Stanley Maintained an Overweight Rating on AbbVie (ABBV)

finance.yahoo.com/news/morgan-stanley-maintained-overweight-rating-142614695.html

In This Article:
AbbVie Inc. (NYSE:ABBV) is one of the best high growth stocks. On June 30, Morgan Stanley maintained an Overweight rating and a $250 price target on AbbVie, in light of the company’s recent acquisition announcement.
Recently, AbbVie announced its intention to acquire…

This story appeared on finance.yahoo.com, 2025-07-09 14:26:14.
The Entire Business World on a Single Page. Free to Use →